143 related articles for article (PubMed ID: 3481241)
1. [Attention to CA 19.9 in alcoholics. Apropos of a case].
Giovannini M; Penalvert F; Maillot A; Escoffier JM; Botta D; Gauthier A
Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):393. PubMed ID: 3481241
[No Abstract] [Full Text] [Related]
2. Estimation of carbohydrate antigen (CA) 19-9 levels in pure pancreatic juice of patients with pancreatic cancer.
Nishida K; Tasaki N; Miyagawa H; Yoshikawa T; Kondo M
Am J Gastroenterol; 1988 Feb; 83(2):126-9. PubMed ID: 3422536
[TBL] [Abstract][Full Text] [Related]
3. [Importance of the tumor-associated antigen CA 19-9 in the differential diagnosis of pancreatic diseases].
Heptner G; Domschke S; Schneider MU; Domschke W
Dtsch Med Wochenschr; 1985 Apr; 110(16):624-8. PubMed ID: 3857159
[TBL] [Abstract][Full Text] [Related]
4. [The contribution of CA 19-9 in the differential diagnosis between chronic pancreatitis and cancer of the pancreas].
Van Gossum M; Delanghe A; Gerard M; Delcourt A; Deltenre M
Acta Gastroenterol Belg; 1987; 50(1):91-4. PubMed ID: 3480672
[No Abstract] [Full Text] [Related]
5. [Comparison of new three tumor markers for pancreatic carcinoma: CA19/9, CA 125 and DuPan 2].
Ohkura H; Sakawaki T
Gan No Rinsho; 1985 May; 31(6 Suppl):583-8. PubMed ID: 3861882
[TBL] [Abstract][Full Text] [Related]
6. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
Klapdor R; Greten H
Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
[No Abstract] [Full Text] [Related]
7. [The tumor markers CA 19.9, Ca 50 and CEA in the differential diagnosis of pancreatic carcinoma].
Röthlin M; Metzger U; Joller H; Largiadèr F
Schweiz Med Wochenschr; 1988 Jun; 118(24):924-9. PubMed ID: 2456610
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract.
Harmenberg U; Wahren B; Wiechel KL
Cancer Res; 1988 Apr; 48(7):1985-8. PubMed ID: 3349472
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
Blind PJ; Dahlgren ST
Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
[TBL] [Abstract][Full Text] [Related]
10. [Alcoholic pancreatitis with special reference to clinical course, diagnosis and differential diagnosis].
Ammann RW
Schweiz Rundsch Med Prax; 1984 May; 73(18):573-7. PubMed ID: 6203159
[No Abstract] [Full Text] [Related]
11. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
Ruibal A; Encabo G
Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374
[TBL] [Abstract][Full Text] [Related]
12. CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis.
Farini R; Fabris C; Bonvicini P; Piccoli A; del Favero G; Venturini R; Panucci A; Naccarato R
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):429-32. PubMed ID: 3859414
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of markers of hepatotrophic viruses in alcoholics with symptomatic liver cirrhosis or pancreatitis.
Stigendal L; Hermodsson S; Olsson R
Scand J Gastroenterol; 1984 Jul; 19(5):588-90. PubMed ID: 6089303
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of recurrence and evaluation of the course of pancreatic cancer. Combined use of sonography and the new tumor marker CA 19-9].
Guthoff A; Klapdor U; Klapdor R; Eichfuss HP; Dallek M; Greten H
Dtsch Med Wochenschr; 1984 Sep; 109(37):1410-2. PubMed ID: 6383759
[No Abstract] [Full Text] [Related]
15. Carbohydrate antigen (CA 19-9)--a valuable tumor marker of pancreatic cancer.
Lin JT; Wang TH; Sung JL; Chen DS
Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):828-35. PubMed ID: 3864924
[No Abstract] [Full Text] [Related]
16. [CA 19-9 and cancer of the pancreas. Critical review of the literature].
Delcourt A
Acta Gastroenterol Belg; 1987; 50(1):1-8. PubMed ID: 3321822
[No Abstract] [Full Text] [Related]
17. [Significance of the determination of serum CA19.9 in patients with tumor or non-tumor pancreatopathies].
Encabo G; Ruibal A; Gefaell R; Martínez Miralles E; Salgado A; Fernández Llamazares J
Med Clin (Barc); 1984 Mar; 82(12):560-1. PubMed ID: 6588282
[No Abstract] [Full Text] [Related]
18. [Biohumeral markers in the diagnosis of pancreatic carcinoma].
Panucci A; Del Favero G; Falmis C; Brosolo P; Basso D; Pedrazzoli S; Baccaglini U; Marchioro L; Bonvilini P; Naccarato R
Recenti Prog Med; 1985; 76(7-8):385-91. PubMed ID: 3865269
[No Abstract] [Full Text] [Related]
19. [Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma].
Nouts A; Lévy P; Voitot H; Bernades P
Gastroenterol Clin Biol; 1998 Feb; 22(2):152-9. PubMed ID: 9762189
[TBL] [Abstract][Full Text] [Related]
20. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
Pezzilli R; Billi P; Plate L; Laudadio MA; Sprovieri G
Ital J Gastroenterol; 1995; 27(6):296-9. PubMed ID: 8562994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]